Global Female Contraceptives Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 122 pages | ID: GBBDB0A16ECEN
GlobalInfoResearch

Abstracts

Birth control medicine used by female.

Scope of the Report:

This report studies the Female Contraceptives market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Female Contraceptives market by product type and applications/end industries.
Need to avoid unwanted pregnancies, especially among the teenage women, is one of the major drivers for this market. Government initiatives, promoting the use of contraceptives to avoid unnecessary births, and health benefits from using contraceptives, have also been important factors, instrumental in market growth.
The global Female Contraceptives market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Female Contraceptives.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Bayer
• Mayer Laboratories
• Pfizer
• Mylan
• Teva
• Merck
• Johnson & Johnson
• Lupin Pharmaceuticals
• Female Health Company
• Fuji Latex

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Contraceptive Drugs
• Contraceptive Devices

Market Segment by Applications, can be divided into

• Personal use
• Hospital

Contents

1 FEMALE CONTRACEPTIVES MARKET OVERVIEW

1.1 Product Overview and Scope of Female Contraceptives
1.2 Classification of Female Contraceptives by Types
  1.2.1 Global Female Contraceptives Revenue Comparison by Types (2017-2023)
  1.2.2 Global Female Contraceptives Revenue Market Share by Types in 2017
  1.2.3 Contraceptive Drugs
  1.2.4 Contraceptive Devices
1.3 Global Female Contraceptives Market by Application
  1.3.1 Global Female Contraceptives Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Personal use
  1.3.3 Hospital
1.4 Global Female Contraceptives Market by Regions
  1.4.1 Global Female Contraceptives Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Female Contraceptives Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Female Contraceptives Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Female Contraceptives Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Female Contraceptives Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Female Contraceptives Status and Prospect (2013-2023)
1.5 Global Market Size of Female Contraceptives (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Bayer
  2.1.1 Business Overview
  2.1.2 Female Contraceptives Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mayer Laboratories
  2.2.1 Business Overview
  2.2.2 Female Contraceptives Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
  2.3.1 Business Overview
  2.3.2 Female Contraceptives Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
  2.4.1 Business Overview
  2.4.2 Female Contraceptives Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva
  2.5.1 Business Overview
  2.5.2 Female Contraceptives Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Teva Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
  2.6.1 Business Overview
  2.6.2 Female Contraceptives Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Merck Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
  2.7.1 Business Overview
  2.7.2 Female Contraceptives Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lupin Pharmaceuticals
  2.8.1 Business Overview
  2.8.2 Female Contraceptives Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.9 Female Health Company
  2.9.1 Business Overview
  2.9.2 Female Contraceptives Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
2.10 Fuji Latex
  2.10.1 Business Overview
  2.10.2 Female Contraceptives Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL FEMALE CONTRACEPTIVES MARKET COMPETITION, BY PLAYERS

3.1 Global Female Contraceptives Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Female Contraceptives Players Market Share
  3.2.2 Top 10 Female Contraceptives Players Market Share
3.3 Market Competition Trend

4 GLOBAL FEMALE CONTRACEPTIVES MARKET SIZE BY REGIONS

4.1 Global Female Contraceptives Revenue and Market Share by Regions
4.2 North America Female Contraceptives Revenue and Growth Rate (2013-2018)
4.3 Europe Female Contraceptives Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Female Contraceptives Revenue and Growth Rate (2013-2018)
4.5 South America Female Contraceptives Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Female Contraceptives Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA FEMALE CONTRACEPTIVES REVENUE BY COUNTRIES

5.1 North America Female Contraceptives Revenue by Countries (2013-2018)
5.2 USA Female Contraceptives Revenue and Growth Rate (2013-2018)
5.3 Canada Female Contraceptives Revenue and Growth Rate (2013-2018)
5.4 Mexico Female Contraceptives Revenue and Growth Rate (2013-2018)

6 EUROPE FEMALE CONTRACEPTIVES REVENUE BY COUNTRIES

6.1 Europe Female Contraceptives Revenue by Countries (2013-2018)
6.2 Germany Female Contraceptives Revenue and Growth Rate (2013-2018)
6.3 UK Female Contraceptives Revenue and Growth Rate (2013-2018)
6.4 France Female Contraceptives Revenue and Growth Rate (2013-2018)
6.5 Russia Female Contraceptives Revenue and Growth Rate (2013-2018)
6.6 Italy Female Contraceptives Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC FEMALE CONTRACEPTIVES REVENUE BY COUNTRIES

7.1 Asia-Pacific Female Contraceptives Revenue by Countries (2013-2018)
7.2 China Female Contraceptives Revenue and Growth Rate (2013-2018)
7.3 Japan Female Contraceptives Revenue and Growth Rate (2013-2018)
7.4 Korea Female Contraceptives Revenue and Growth Rate (2013-2018)
7.5 India Female Contraceptives Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Female Contraceptives Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA FEMALE CONTRACEPTIVES REVENUE BY COUNTRIES

8.1 South America Female Contraceptives Revenue by Countries (2013-2018)
8.2 Brazil Female Contraceptives Revenue and Growth Rate (2013-2018)
8.3 Argentina Female Contraceptives Revenue and Growth Rate (2013-2018)
8.4 Colombia Female Contraceptives Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE FEMALE CONTRACEPTIVES BY COUNTRIES

9.1 Middle East and Africa Female Contraceptives Revenue by Countries (2013-2018)
9.2 Saudi Arabia Female Contraceptives Revenue and Growth Rate (2013-2018)
9.3 UAE Female Contraceptives Revenue and Growth Rate (2013-2018)
9.4 Egypt Female Contraceptives Revenue and Growth Rate (2013-2018)
9.5 Nigeria Female Contraceptives Revenue and Growth Rate (2013-2018)
9.6 South Africa Female Contraceptives Revenue and Growth Rate (2013-2018)

10 GLOBAL FEMALE CONTRACEPTIVES MARKET SEGMENT BY TYPE

10.1 Global Female Contraceptives Revenue and Market Share by Type (2013-2018)
10.2 Global Female Contraceptives Market Forecast by Type (2018-2023)
10.3 Contraceptive Drugs Revenue Growth Rate (2013-2023)
10.4 Contraceptive Devices Revenue Growth Rate (2013-2023)

11 GLOBAL FEMALE CONTRACEPTIVES MARKET SEGMENT BY APPLICATION

11.1 Global Female Contraceptives Revenue Market Share by Application (2013-2018)
11.2 Female Contraceptives Market Forecast by Application (2018-2023)
11.3 Personal use Revenue Growth (2013-2018)
11.4 Hospital Revenue Growth (2013-2018)

12 GLOBAL FEMALE CONTRACEPTIVES MARKET SIZE FORECAST (2018-2023)

12.1 Global Female Contraceptives Market Size Forecast (2018-2023)
12.2 Global Female Contraceptives Market Forecast by Regions (2018-2023)
12.3 North America Female Contraceptives Revenue Market Forecast (2018-2023)
12.4 Europe Female Contraceptives Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Female Contraceptives Revenue Market Forecast (2018-2023)
12.6 South America Female Contraceptives Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Female Contraceptives Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Female Contraceptives Picture
Table Product Specifications of Female Contraceptives
Table Global Female Contraceptives and Revenue (Million USD) Market Split by Product Type
Figure Global Female Contraceptives Revenue Market Share by Types in 2017
Figure Contraceptive Drugs Picture
Figure Contraceptive Devices Picture
Table Global Female Contraceptives Revenue (Million USD) by Application (2013-2023)
Figure Female Contraceptives Revenue Market Share by Applications in 2017
Figure Personal use Picture
Figure Hospital Picture
Table Global Market Female Contraceptives Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Female Contraceptives Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Female Contraceptives Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Female Contraceptives Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Female Contraceptives Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Female Contraceptives Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Female Contraceptives Revenue (Million USD) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Female Contraceptives Type and Applications
Table Bayer Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Mayer Laboratories Basic Information, Manufacturing Base and Competitors
Table Mayer Laboratories Female Contraceptives Type and Applications
Table Mayer Laboratories Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Female Contraceptives Type and Applications
Table Pfizer Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Female Contraceptives Type and Applications
Table Mylan Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Female Contraceptives Type and Applications
Table Teva Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Female Contraceptives Type and Applications
Table Merck Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Female Contraceptives Type and Applications
Table Johnson & Johnson Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Lupin Pharmaceuticals Female Contraceptives Type and Applications
Table Lupin Pharmaceuticals Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Female Health Company Basic Information, Manufacturing Base and Competitors
Table Female Health Company Female Contraceptives Type and Applications
Table Female Health Company Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Fuji Latex Basic Information, Manufacturing Base and Competitors
Table Fuji Latex Female Contraceptives Type and Applications
Table Fuji Latex Female Contraceptives Revenue, Gross Margin and Market Share (2016-2017)
Table Global Female Contraceptives Revenue (Million USD) by Players (2013-2018)
Table Global Female Contraceptives Revenue Share by Players (2013-2018)
Figure Global Female Contraceptives Revenue Share by Players in 2016
Figure Global Female Contraceptives Revenue Share by Players in 2017
Figure Global Top 5 Players Female Contraceptives Revenue Market Share in 2017
Figure Global Top 10 Players Female Contraceptives Revenue Market Share in 2017
Figure Global Female Contraceptives Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Female Contraceptives Revenue (Million USD) by Regions (2013-2018)
Table Global Female Contraceptives Revenue Market Share by Regions (2013-2018)
Figure Global Female Contraceptives Revenue Market Share by Regions (2013-2018)
Figure Global Female Contraceptives Revenue Market Share by Regions in 2017
Figure North America Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Europe Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure South America Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Female Contraceptives Revenue and Growth Rate (2013-2018)
Table North America Female Contraceptives Revenue by Countries (2013-2018)
Table North America Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure North America Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure North America Female Contraceptives Revenue Market Share by Countries in 2017
Figure USA Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Canada Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Mexico Female Contraceptives Revenue and Growth Rate (2013-2018)
Table Europe Female Contraceptives Revenue (Million USD) by Countries (2013-2018)
Figure Europe Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure Europe Female Contraceptives Revenue Market Share by Countries in 2017
Figure Germany Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure UK Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure France Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Russia Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Italy Female Contraceptives Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Female Contraceptives Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Female Contraceptives Revenue Market Share by Countries in 2017
Figure China Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Japan Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Korea Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure India Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Female Contraceptives Revenue and Growth Rate (2013-2018)
Table South America Female Contraceptives Revenue by Countries (2013-2018)
Table South America Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure South America Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure South America Female Contraceptives Revenue Market Share by Countries in 2017
Figure Brazil Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Argentina Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Colombia Female Contraceptives Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Female Contraceptives Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Female Contraceptives Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Female Contraceptives Revenue Market Share by Countries in 2017
Figure Saudi Arabia Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure UAE Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Egypt Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure Nigeria Female Contraceptives Revenue and Growth Rate (2013-2018)
Figure South Africa Female Contraceptives Revenue and Growth Rate (2013-2018)
Table Global Female Contraceptives Revenue (Million USD) by Type (2013-2018)
Table Global Female Contraceptives Revenue Share by Type (2013-2018)
Figure Global Female Contraceptives Revenue Share by Type (2013-2018)
Figure Global Female Contraceptives Revenue Share by Type in 2017
Table Global Female Contraceptives Revenue Forecast by Type (2018-2023)
Figure Global Female Contraceptives Market Share Forecast by Type (2018-2023)
Figure Global Contraceptive Drugs Revenue Growth Rate (2013-2018)
Figure Global Contraceptive Devices Revenue Growth Rate (2013-2018)
Table Global Female Contraceptives Revenue by Application (2013-2018)
Table Global Female Contraceptives Revenue Share by Application (2013-2018)
Figure Global Female Contraceptives Revenue Share by Application (2013-2018)
Figure Global Female Contraceptives Revenue Share by Application in 2017
Table Global Female Contraceptives Revenue Forecast by Application (2018-2023)
Figure Global Female Contraceptives Market Share Forecast by Application (2018-2023)
Figure Global Personal use Revenue Growth Rate (2013-2018)
Figure Global Hospital Revenue Growth Rate (2013-2018)
Figure Global Female Contraceptives Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Female Contraceptives Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Female Contraceptives Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Female Contraceptives Revenue Market Forecast (2018-2023)
Figure Europe Female Contraceptives Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Female Contraceptives Revenue Market Forecast (2018-2023)
Figure South America Female Contraceptives Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Female Contraceptives Revenue Market Forecast (2018-2023)